ORAMED PHARMACEUTICALS INC. 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Feb 16, 2017
Insider Transaction Report
Form 4
Slager David Mark
10% Owner
Transactions
- Award
Stock Option (right to buy)
2017-02-09+5,697→ 5,697 totalExercise: $6.23Exp: 2027-02-09→ Common Stock (5,697 underlying)
Footnotes (1)
- [F1]The Stock Option will vest immediately.